EFFICACY OF INDUCTION UPADACITINIB THERAPY IN EAST ASIAN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Minhu Chen  1     Gao Xiang  2     Kenji Watanabe  3     Toshimitsu Fujii  4     Jae Hee Cheon  5     Shu Chen Wei  6     Dennis Teng  7     Ana Paula Machado De Lacerda  7     Valencia Remple  7     Hiroshi Nakase  8    
1 The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
2 The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
3 Hyogo Medical University, Nishinomiya, Japan
4 Tokyo Medical and Dental University, Tokyo, Japan
5 Yonsei University, Seoul, Korea, Republic of
6 National Taiwan University Hospital, Taipei, Taiwan, Province of China
7 AbbVie Inc., North Chicago, United States
8 Sapporo Medical University, Sapporo, Japan

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing